ClinicalTrials.gov
public full text
Public Domain
DuoTrav APS Versus XALACOM® in Ocular Surface Health
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG#172446
- Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection#968272
- A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)#1088686
- Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle Glaucoma#160194
- Performance of Systane PRO Versus Refresh Optive Mega-3#1075565
Record · ID 651139
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive